Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus antibodies in Upper Guinea, West Africa

Tropical Medicine and International Health

Volumn 18, Issue 3, 2013, Pages 366-371

  Klempa, Boris ^a,b   Koulemou, Kekoura ^c   Auste, Brita ^a   Emmerich, Petra ^d   Thomé Bolduan, Corinna ^d   Günther, Stephan ^d   Koivogui, Lamine ^c   Krüger, Detlev H ^a   Fichet Calvet, Elisabeth ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c Guinée Centre de Recherche et de Formation en Infectiologie de Guinée Guinean infectiology research and training center   (Guinea)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Guinea; Hantavirus; Lassa virus; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY; COEXISTENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH RISK; IMMUNOASSAY; INFECTIOUS DISEASE; PARTICIPATORY APPROACH; PUBLIC HEALTH; SUBPOPULATION; VIRAL DISEASE;

ADULT; AFRICA; AGED; ARTICLE; FEMALE; FEVER; HANTAVIRUS; HANTAVIRUS INFECTION; HUMAN; IMMUNOFLUORESCENCE; INFECTIOUS DISEASE ELISA KIT; LASSA FEVER; LASSA VIRUS; MAJOR CLINICAL STUDY; MALE; SEROEPIDEMIOLOGY; SEROPREVALENCE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; COINFECTION; FEMALE; GUINEA; HANTAVIRUS INFECTIONS; HUMANS; LASSA FEVER; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEROEPIDEMIOLOGIC STUDIES;

GUINEA;

HANTAVIRUS; LASSA VIRUS;

EID: 84873999790     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12045     Document Type: Article

References (31)

1. Bausch DG, Demby AH, Coulibaly M et al. (2001) Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne and Zoonotic Diseases 1, 269-281.
2. Charrel RN & de Lamballerie X (2003) Arenaviruses other than Lassa virus. Antiviral Research 57, 89-100.
3. Dupont A, Gonzalez JP, Georges A & Ivanoff B (1987) Seroepidemiology of Hantaan-related virus in Gabon. Transactions of the Royal Society for Tropical Medicine and Hygiene 81, 519.
4. Emmerich P, Thome-Bolduan C, Drosten C et al. (2006) Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. Journal of Clinical Virology 37, 277-281.
5. Fichet-Calvet E, Lecompte E, Koivogui L et al. (2007) Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne and Zoonotic Diseases 7, 119-128.
6. Fichet-Calvet E, Lecompte E, Koivogui L, Daffis S & ter MJ (2008) Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa. Vector Borne and Zoonotic Diseases 8, 41-48.
7. Fichet-Calvet E, Audenaert L, Barriere P & Verheyen E (2010) Diversity, dynamics and reproduction in a community of small mammals in Upper Guinea, with emphasis on pygmy mice ecology. African Journal of Ecology 48, 600-614.
8. Gonzalez JP, Mathiot CC, Bouquety JC et al. (1988) Status of Hantavirus in the Central African Republic. Annales de l'Institut Pasteur. Virology 139, 301-304.
9. Gunther S & Lenz O (2004) Lassa virus. Critical Reviews in Clinical Laboratory Sciences 41, 339-390.
10. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH & King IJ (1987) "Clinical virology of Lassa fever in hospitalized patients." Journal of Infectious Diseases 155(3), 456-464.
11. Kerneis S, Koivogui L, Magassouba N et al. (2009) Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Neglected Tropical Diseases 3, e548.
12. Klempa B, Fichet-Calvet E, Lecompte E et al. (2006) Hantavirus in African wood mouse, Guinea. Emerging Infectious Diseases 12, 838-840.
13. Klempa B, Fichet-Calvet E, Lecompte E et al. (2007) Novel hantavirus sequences in Shrew, Guinea. Emerging Infectious Diseases 13, 520-522.
14. Klempa B, Koivogui L, Sylla O et al. (2010) Serological evidence of human hantavirus infections in Guinea, West Africa. Journal of Infectious Diseases 201, 1031-1034.
15. Klempa B, Witkowski PT, Popugaeva E et al. (2012) Sangassou virus, the first hantavirus isolate from Africa, displays distinct genetic and functional properties in the group of Murinae-associated hantaviruses. Journal of Virology 86, 3819-3827.
16. Kruger DH, Ulrich R & Lundkvist A (2001) Hantavirus infections and their prevention. Microbes and Infection 3, 1129-1144.
17. Kruger DH, Schonrich G & Klempa B (2011) Human pathogenic hantaviruses and prevention of infection. Human Vaccines 7, 685-693.
18. Lecompte E, Fichet-Calvet E, Daffis S et al. (2006) Mastomys natalensis and Lassa fever, West Africa. Emerging Infectious Diseases 12, 1971-1974.
19. Lecompte E, ter MJ, Emonet S, Daffis S & Charrel RN (2007) Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa. Virology 364, 178-183.
20. Lukashevich LS, Clegg JC & Sidibe K (1993) Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. Journal of Medical Virology 40, 210-217.
21. McCormick JB (1999) Lassa fever. In: Emergence and control of rodent-borne viral diseases. (eds JF Saluzzo & B Dodet ) Elsevier, Paris, pp. 177-195.
22. Meisel H, Wolbert A, Razanskiene A et al. (2006) Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clinical Vaccine Immunology 13, 1349-1357.
23. ter Meulen J, Lukashevich I, Sidibe K et al. (1996) Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. American Journal of Tropical Medicine and Hygiene 55, 661-666.
24. Olschlager S, Lelke M, Emmerich P et al. (2010) Improved detection of Lassa virus by reverse transcription-PCR targeting the 5′ region of S RNA. Journal of Clinical Microbiology 48(200), 9-2013.
25. Paweska JT, Sewlall NH, Ksiazek TG et al. (2009) Nosocomial outbreak of novel arenavirus infection, Southern Africa. Emerging Infectious Diseases 15, 1598-1602.
26. Peters CJ & Khan AS (2002) Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clinical Infectious Diseases 34, 1224-1231.
27. Schilling S, Emmerich P, Klempa B et al. (2007) Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. Journal of Clinical Microbiology 45, 3008-3014.
28. Schmaljohn C & Hjelle B (1997) Hantaviruses: a global disease problem. Emerging Infectious Diseases 3, 95-104.
29. Wulff H & Johnson KM (1979) Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bulletin of the World Health Organisation 57, 631-635.
30. Wulff H & Lange JV (1975) Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bulletin of the World Health Organisation 52, 429-436.
31. Zöller L, Faulde M, Meisel H et al. (1995) Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. European Journal of Clinical Microbiology and Infectious Diseases 14, 305-313.